boehringer, stencel

REVERSED

1600 Biotechnology and Organic Chemistry
1611 Ex Parte Pilgaard et al 10/490,278 McCOLLUM 103(a) COLOPLAST A/S EXAMINER GHALI, ISIS A D

2400 Networking, Mulitplexing, Cable, and Security
2444 Ex Parte Trossman et al 10/947,768 DILLON 103(a)/101 LEE LAW, PLLC IBM CUSTOMER NUMBER EXAMINER BENGZON, GREG C

2448 Ex Parte Brownholtz et al 10/894,526 DROESCH 102(b)/103(a) 37 C.F.R. § 41.50(b) 102(e) CAREY, RODRIGUEZ, GREENBERG & O''KEEFE, LLP STEVEN M. GREENBERG EXAMINER WHIPPLE, BRIAN P

2478 Ex Parte Barda 10/836,520 CHEN 102(b) KENYON & KENYON LLP EXAMINER ALI, FARHAD

2800 Semiconductors, Electrical and Optical Systems and Components
2857 Ex Parte Coss et al 10/094,550 KRIVAK 102(b) HAMILTON & TERRILE, LLP EXAMINER NGHIEM, MICHAEL P
AFFIRMED-IN-PART

1600 Biotechnology and Organic Chemistry
1631 Ex Parte Wong et al 10/794,334 WALSH 103(a) nonstatutory obviousness-type double patenting VISTA IP LAW GROUP LLP EXAMINER WHALEY, PABLO S

2100 Computer Architecture and Software
2111 Ex Parte Asaro et al 10/074,064 SMITH 103(a) 103(a) VEDDER PRICE P.C. EXAMINER MYERS, PAUL R

2185 Ex Parte Challener et al 11/068,322 DESHPANDE 112(2)/103(a) 103(a) ROGITZ & ASSOCIATES EXAMINER THAI, TUAN V

2400 Networking, Mulitplexing, Cable, and Security
2491 Ex Parte Huynh et al 10/457,908 FRAHM 103(a) 101 STEVENS & SHOWALTER, L.L.P. BOX IBM EXAMINER POPHAM, JEFFREY D

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3612 Ex Parte Balzer et al 11/480,618 BAHR 103(a) 103(a) MILLER LAW GROUP, PLLC AND FORD GLOBAL TECHNOLOGIES, INC. EXAMINER CHENEVERT, PAUL A
AFFIRMED

1600 Biotechnology and Organic Chemistry
1627 Ex Parte Weers et al 10/751,342 WALSH 103(a)/nonstatutory obviousness-type double patenting NOVARTIS EXAMINER CARTER, KENDRA D

1644 Ex Parte Peritt et al 11/018,240 McCOLLUM 103(a) PHILIP S. JOHNSON JOHNSON & JOHNSON EXAMINER SKELDING, ZACHARY S

1645 Ex Parte Chu 11/325,556 FRANKLIN 103(a) WYETH LLC EXAMINER GANGLE, BRIAN J

1700 Chemical & Materials Engineering
1742 Ex Parte Breese 10/774,161 GARRIS 103(a) LyondellBasell Industries EXAMINER VARGOT, MATHIEU D

2100 Computer Architecture and Software
2112 Ex Parte Raith et al 11/098,292 DESHPANDE 102(b)/103(a) COATS & BENNETT, PLLC EXAMINER TORRES, JOSEPH D

2172 Ex Parte Schmitt 10/854,170 COURTENAY 103(a) SAP / FINNEGAN, HENDERSON LLP EXAMINER SONG, DAEHO D

Appellant’s argued limitation of “performing a query on a database for determining names of one or more predefined parameter sets for the customization object” (claim 1) does not positively recite that any parameter set names are actually determined. Our reviewing court guides that “[a]n intended use or purpose usually will not limit the scope of the claim because such statements usually do no more than define a context in which the invention operates.” Boehringer Ingelheim Vetmedica, Inc. v. Schering-Plough Corp., 320 F.3d 1339, 1345 (Fed. Cir. 2003). Although “[s]uch statements often . . . appear in the claim’s preamble,” In re Stencel, 828 F.2d 751, 754 (Fed. Cir. 1987), a statement of intended use or purpose can appear elsewhere in a claim. Id.

Stencel, In re, 828 F.2d 751, 4 USPQ2d 1071 (Fed. Cir. 1987) . . . . . . . . . . . . . . . . .2111.02

2600 Communications
2617 Ex Parte Willins et al 11/137,003 HAHN 103(a) MOTOROLA SOLUTIONS, INC. EXAMINER LAI, DANIEL

2618 Ex Parte Perlman 10/395,749 GONSALVES 102(e)/103(a) THE LAW OFFICES OF BRADLEY J. BEREZNAK EXAMINER NGUYEN, TU X

3700 Mechanical Engineering, Manufacturing, and Products & Design
3761 Ex Parte Hirotsu 10/719,321 GRIMES 103(a) THE PROCTER & GAMBLE COMPANY EXAMINER CRAIG, PAULA L

3788 Ex Parte Ryan et al 11/132,964 ASTORINO 102(b)/103(a) THE WEINTRAUB GROUP, P.L.C. EXAMINER PICKETT, JOHN G
REHEARING

GRANTED-IN-PART

1600 Biotechnology and Organic Chemistry
1656 Ex Parte Wei et al 12/283,347 ADAMS 112(1) HUGH MCTAVISH MCTAVISH PATENT FIRM EXAMINER MONSHIPOURI, MARYAM